Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Avantor, Inc. Common Stock (NY:AVTR)

12.76 -0.17 (-1.31%)
Official Closing Price Updated: 7:00 PM EDT, Aug 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Avantor, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
Avantor, Viatris, and Amneal Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation of an impending interest rate cut by the Federal Reserve. Following a favorable Consumer... 
Via StockStory
Topics Artificial Intelligence Economy
AVTR Q2 Deep Dive: Margin Pressures Mount as Competitive Intensity Rises and Leadership Transition Looms
Life sciences company Avantor (NYSE:AVTR) reported Q2 CY2025 results topping the market’s revenue expectations, but sales fell by 1.1% year on year to $1.68 billion. Its non-GAAP profit of $0.24 per... 
Via StockStory
Topics Economy
Revvity, Avantor, Azenta, Bio-Techne, and Amneal Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after positive inflation data fueled hopes for an interest rate cut by the Federal Reserve. The latest Consumer Price Index (CPI) report showed... 
Via StockStory
Topics Bonds Economy Stocks
Avantor Responds To Activist Investor Engine Capital’s Letter: ‘Acting With Urgency To Strengthen Growth’
Via Stocktwits
Why Avantor (AVTR) Stock Is Trading Up Today
Shares of life sciences company Avantor (NYSE:AVTR) jumped 6.1% in the morning session after activist investor Engine Capital disclosed it is pushing the company to explore a potential sale or make... 
Via StockStory
Avantor Stock Jumps As Activist Investor Urges Sale, Board Shake-Up, And Cost Cuts
Engine Capital, holding a 3% stake in Avantor, urges the board to pursue a turnaround or sale, citing years of underperformance, missed targets, and lost market share. 
Via Benzinga
Avantor Surges As Activist Investor Takes Aim At 'Self-Inflicted' Issues
The investor is digging in to improve years of share decline, saying the company can improve its cost discipline and turnover. 
Via Investor's Business Daily
Topics Supply Chain
Trump-Era Funding Cuts Add Pressure On This Life Sciences Stock — Activist Investor Eyes Sale At Up To 65% Premium
Via Stocktwits
Earnings Preview For Avantor
 
Via Benzinga
Avantor Q2 Revenue Tops Estimates
Via The Motley Fool
Topics Supply Chain
Avantor: A Century of Scientific Purity and Global Impact
Avantor (NYSE: AVTR) is a global leader in providing mission-critical products and services to customers in the life sciences and advanced technology industries. Headquartered in Radnor, Pennsylvania,... 
Via MarketMinute
Topics Artificial Intelligence Emissions Initial Public Offering
Avantor Shares Plummet Amidst Broader Market Turmoil and Company-Specific Headwinds
Avantor (NYSE: AVTR) shares have recently experienced a significant and sustained plunge, hitting a 52-week low and reflecting a challenging period for the life sciences company. This sharp decline is... 
Via MarketMinute
Topics Artificial Intelligence Economy Initial Public Offering
Avantor Q2 Feels The Impact From Bioprocessing Shortfalls, Customer Headwinds, Continued Margin Pressure
Avantor missed Q2 EPS expectations as weak bioprocessing sales and customer disruptions pressured earnings, despite flat organic growth and a CEO change. 
Via Benzinga
Why Avantor (AVTR) Shares Are Plunging Today
Shares of life sciences company Avantor (NYSE:AVTR) fell 15.5% in the morning session after the company reported disappointing second-quarter results and cut its full-year financial forecast. The... 
Via StockStory
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
Avantor Inc (NYSE:AVTR) Q2 2025 Earnings Miss Estimates, Stock Plunges 7% in Pre-Market Trading
Avantor Inc (NYSE:AVTR) reported Q2 2025 earnings below estimates, with revenue at $1.68B and EPS of $0.24, sparking a 7.1% pre-market stock drop. Weak demand and margin pressures drove the miss. 
Via Chartmill
Topics Earnings
Avantor (NYSE:AVTR) Exceeds Q2 Expectations But Stock Drops
Life sciences company Avantor (NYSE:AVTR) announced better-than-expected revenue in Q2 CY2025, but sales fell by 1.1% year on year to $1.68 billion. Its non-GAAP profit of $0.24 per share was in line... 
Via StockStory
What To Expect From Avantor’s (AVTR) Q2 Earnings
Life sciences company Avantor (NYSE:AVTR) will be announcing earnings results this Friday before market hours. Here’s what to expect. 
Via StockStory
Topics Artificial Intelligence World Trade
Why Avantor (AVTR) Shares Are Trading Lower Today
Shares of life sciences company Avantor (NYSE:AVTR) fell 8% in the afternoon session after the company announced that it has appointed Emmanuel Ligner as its new President and Chief Executive Officer,... 
Via StockStory
Earnings Scheduled For August 1, 2025
 
Via Benzinga
3 Small-Cap Stocks Facing Headwinds
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside... 
Via StockStory
2 Profitable Stocks to Target This Week and 1 to Brush Off
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow. 
Via StockStory
3 Healthcare Stocks with Mounting Challenges
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of... 
Via StockStory
Topics Stocks
3 Cash-Producing Stocks with Mounting Challenges
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. 
Via StockStory
Guardant Health, Evolent Health, Charles River Laboratories, Avantor, and Lumen Stocks Trade Down, What You Need To Know
A number of stocks fell in the afternoon session after the major indices pulled back (Nasdaq -1.3%, S&P 500 - 1.4%) as Treasury yields rose, reflecting market anxiety over a draft federal budget that... 
Via StockStory
Topics Bonds Stocks
Waters Corporation, Avantor, Azenta, Bio-Techne, and Elanco Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after the major indices popped (Nasdaq +3.4%, S&P 500 +2.5%) in response to the positive outcome of U.S.-China trade negotiations, as both sides... 
Via StockStory
Topics Government Stocks World Trade
AVTR Q1 Earnings Call: CEO Transition and Margin Focus Amid Weak Market Conditions
Life sciences company Avantor (NYSE:AVTR) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 5.9% year on year to $1.58 billion. Its non-GAAP profit of $0.23 per share was in... 
Via StockStory
Topics Economy World Trade
Q1 Earnings Highs And Lows: Avantor (NYSE:AVTR) Vs The Rest Of The Research Tools & Consumables Stocks
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Avantor (NYSE:AVTR) and the best and worst... 
Via StockStory
Topics Economy
3 Small-Cap Stocks with Mounting Challenges
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a... 
Via StockStory
Goldman Sachs Downgrades Avantor As Shares Spiral 60% Since 2021: 'We Wrongly Assumed...'
Avantor missed Q1 sales estimates and faced multiple analyst downgrades as concerns mount over growth, competition, and product performance. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.